Patents by Inventor Kang Ting

Kang Ting has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • SEMICONDUCTOR DEVICE AND FABRICATION METHOD THEREOF
    Publication number: 20130075796
    Abstract: A method of fabricating a semiconductor device is disclosed. A dummy gate feature is formed between two active gate features over a substrate. An isolation structure is in the substrate and the dummy gate feature is over the isolation structure. In at least one embodiment, a non-conductive material is used for forming the dummy gate feature to replace a sacrificial gate electrode.
    Type: Application
    Filed: September 28, 2011
    Publication date: March 28, 2013
    Applicant: TAIWAN SEMICONDUCTOR MANUFACTURING COMPANY, LTD.
    Inventors: Tsung-Chieh TSAI, Yung-Che Albert SHIH, Jyh-Kang TING
  • Perivascular Stem Cell Composition For Bone
    Publication number: 20120244128
    Abstract: Embodiments of the present invention provide an osteogenic composition comprising perivascular stem cells or induced pluripotent cells (iPS) and an osteogenic agent and methods of making and using the same.
    Type: Application
    Filed: February 10, 2012
    Publication date: September 27, 2012
    Applicant: THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
    Inventors: B. Chia Soo, Kang Ting, Bruno Peault
  • Cardiac Compositions
    Publication number: 20120237560
    Abstract: Embodiments of the present invention provide a composition comprising perivascular stem cells or induced pluripotent cells (iPS) and a NELL-1 factor for cardiac or vascular regeneration and methods of making and using the same.
    Type: Application
    Filed: February 10, 2012
    Publication date: September 20, 2012
    Applicant: THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
    Inventors: B. Chia Soo, Kang Ting, Bruno Peault
  • High Speed Test Circuit and Method
    Publication number: 20120229146
    Abstract: A high speed test circuit receives a tester clock from a tester and it conducts a test on a circuit under test. The high speed test circuit generates a high frequency clock according to the tester clock, so it is capable of operating in two frequencies. The high speed test circuit tests the circuit under test according to the high frequency clock, and it performs a low speed operation according to a low frequency clock, which is for example the tester clock.
    Type: Application
    Filed: March 2, 2012
    Publication date: September 13, 2012
    Inventors: Tah-Kang Ting, Gyh-Bin Wang, Ming-Hung Wang, Chun-Peng Wu, Li-Chin Tien
  • Transcutaneous Multimodal Delivery System (TMDS)
    Publication number: 20120220981
    Abstract: A transcutaneous multimodal delivery device for drug delivery and the methods of making and using the same are provided.
    Type: Application
    Filed: January 25, 2012
    Publication date: August 30, 2012
    Applicant: THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
    Inventors: B. Chia Soo, Kang Ting, Ben Wu, Kevin Zhang
  • Fibromodulin Peptide
    Publication number: 20120171253
    Abstract: Embodiments of the present invention provide a fibromodulin (FMOD) peptide (FMOD-P), a composition and a formulation comprising a FMOD-P, optionally with a TGF-? isoform, or comprising FMOD with a TGF-? isoform. The present invention also provides methods of making and using the FMOD-P, composition, or formulation.
    Type: Application
    Filed: May 26, 2010
    Publication date: July 5, 2012
    Applicant: The Regents of the University of California
    Inventors: B. Chia Soo, Kang Ting, Zhong Zheng
  • NELL-1 enhanced bone mineralization
    Patent number: 8207120
    Abstract: Provided herein are methods for enhancing bone mineralization for bone repair or regeneration and compositions and grafts therefor. Methods for screening agents that enhance or modulate NELL-1 gene expression or NELL-1 protein production in a cell are also provided.
    Type: Grant
    Filed: January 21, 2011
    Date of Patent: June 26, 2012
    Assignee: The Regents of the University of California
    Inventor: Kang Ting
  • Expression System Of NELL Peptide
    Publication number: 20120077742
    Abstract: Recombinant NELL peptides and methods of preparing the same are disclosed.
    Type: Application
    Filed: October 5, 2011
    Publication date: March 29, 2012
    Applicant: The Regents of the University of California
    Inventors: Kang Ting, Shunichi Kuroda, Ben Wu
  • ISOFORM NELL-1 PEPTIDE
    Publication number: 20120065574
    Abstract: This application generally relates to an isoform Nell-1 peptide, compositions thereof, and methods of using the same.
    Type: Application
    Filed: March 24, 2010
    Publication date: March 15, 2012
    Applicant: THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
    Inventors: Kang Ting, Chia Soo
  • PHARMACEUTICAL COMPOSITIONS FOR TREATING OR PREVENTING BONE CONDITIONS
    Publication number: 20110300184
    Abstract: Provided herein is a pharmaceutical composition for treating, preventing or ameliorating a bone or cartilage condition and methods of making and using the same.
    Type: Application
    Filed: October 4, 2010
    Publication date: December 8, 2011
    Applicant: The Regents of the University of California
    Inventors: Chia Soo, Kang Ting, Shunichi Kuroda, Ben Wu
  • NELL-1 peptides
    Patent number: 8053412
    Abstract: Recombinant NELL peptides and methods of preparing the same are disclosed.
    Type: Grant
    Filed: February 4, 2010
    Date of Patent: November 8, 2011
    Assignee: The Regents of the University of California
    Inventors: Kang Ting, Shunichi Kuroda, Ben Wu
  • NELL peptide expression systems and bone formation activity of NELL peptide
    Patent number: 8048646
    Abstract: The invention generally relates to a bone growth factor, and more particularly to compositions including NELL1, articles of manufacture including NELL1 and methods of using NELL1 to induce bone formation. This invention also provides methods for the expression and purification of NELL1 and NELL2 peptides.
    Type: Grant
    Filed: March 9, 2009
    Date of Patent: November 1, 2011
    Assignee: The Regents of the University of California
    Inventors: Kang Ting, Shunichi Kuroda, Ben Wu
  • RECOMBINANT NELL PROTEIN PRODUCTION
    Publication number: 20110263835
    Abstract: The present invention provides a method and system for producing a NELL protein. The method and system comprise a CELL encoding a NELL protein or peptide and a non-insect secretory signal peptide.
    Type: Application
    Filed: October 7, 2009
    Publication date: October 27, 2011
    Applicant: The Regents of the University of California
    Inventors: Kang Ting, Chia Soo
  • Composition for promoting cartilage formation or repair comprising a NELL gene product and method of treating cartilage-related conditions using such composition
    Patent number: 8044026
    Abstract: Provided herein are a composition for promoting cartilage formation or regeneration comprising a NELL gene product and a method of treating cartilage-related conditions using such a composition.
    Type: Grant
    Filed: February 4, 2010
    Date of Patent: October 25, 2011
    Assignee: The Regents of the University of California
    Inventors: Kang Ting, Ben Wu, Chia Soo
  • NELL-1 ENHANCED BONE MINERALIZATION
    Publication number: 20110212893
    Abstract: Provided herein are methods for enhancing bone mineralization for bone repair or regeneration and compositions and grafts therefor. Methods for screening agents that enhance or modulate NELL-1 gene expression or NELL-1 protein production in a cell are also provided.
    Type: Application
    Filed: January 21, 2011
    Publication date: September 1, 2011
    Applicant: The Regents of the University of California
    Inventor: KANG TING
  • NELL-1 ENHANCED BONE MINERALIZATION
    Publication number: 20110044956
    Abstract: This invention pertains to the discovery that the human NELL-1 gene induces or upregulates bone mineralization. The NELL-1 gene or gene product thus provides a convenient target for screening for modulators of bone mineralization. In addition, NELL-1 can be used to facilitate repair of bone fractures and/or to generally increase bone density.
    Type: Application
    Filed: July 29, 2010
    Publication date: February 24, 2011
    Inventor: KANG TING
  • NELL-1 enhanced bone mineralization
    Patent number: 7884066
    Abstract: Provided herein are methods for enhancing bone mineralization for bone repair or regeneration and compositions and grafts therefor. Methods for screening agents that enhance or modulate NELL-1 gene expression or NELL-1 protein production in a cell are also provided.
    Type: Grant
    Filed: March 1, 2007
    Date of Patent: February 8, 2011
    Assignee: The Regents of the University of California
    Inventor: Kang Ting
  • Pharmaceutical compositions for treating or preventing bone conditions
    Patent number: 7833968
    Abstract: Provided in the present application is a pharmaceutical composition for treating, preventing, or ameliorating a bone or cartilage condition and methods of making and using the same.
    Type: Grant
    Filed: February 16, 2006
    Date of Patent: November 16, 2010
    Assignee: The Regents of the University of California
    Inventors: Chia Soo, Kang Ting, Shunichi Kuroda, Ben Wu
  • NELL-1 peptide
    Patent number: 7807787
    Abstract: The invention generally relates to a bone growth factor, and more particularly to compositions including NELL1, articles of manufacture including NELL1 and methods of using NELL1 to induce bone formation. This invention also provides methods for the expression and purification of NELL1 and NELL2 peptides.
    Type: Grant
    Filed: March 9, 2009
    Date of Patent: October 5, 2010
    Assignee: The Regents of The University of California
    Inventors: Kang Ting, Shunichi Kuroda, Ben Wu
  • NELL Peptide Expression Systems and Bone Formation Activity of NELL Peptide
    Publication number: 20100249376
    Abstract: The invention generally relates to a bone growth factor, and more particularly to compositions including NELL1, articles of manufacture including NELL1 and methods of using NELL1 to induce bone formation. This invention also provides methods for the expression and purification of NELL1 and NELL2 peptides.
    Type: Application
    Filed: March 9, 2009
    Publication date: September 30, 2010
    Inventors: Kang Ting, Shunichi Kuroda, Ben Wu